Friends of the ATA
FREE Public Health Forum
Saturday, September 22, 2012
1:00 – 3:00 pm
Hilton Quebec – Beauport, 2nd Fl.
Thyroid Disease and You
Could it be your thyroid?
The ATA Alliance for Patient Education with Thyroid Experts, Thyroid Patients, and You More information....

Follow us on Twitter at @thyroidfriends. Get the most up-to-date thyroid news fast and easy! Be the most informed thyroid patient in the waiting room. Please feel free to submit questions as well as suggestions as to how we can better serve thyroid patients. Twitter

Check us out on Facebook: www.facebook.com/thyroidassociation. ATA is on Facebook

 

Clinical Thyroidology for Patients Give Now
Up-to-date information to help you understand thyroid disease through the latest research.

In this issue, the studies ask the following questions:

  • Is there an easier and quicker way to diagnose thyroid storm?
  • Can a new test actually predict remission in Graves' disease?
  • Can patients with pituitary disease be hypothyroid with normal thyroid blood tests?
  • Are there alternatives to surgery to TSH-secreting pituitary tumors?
  • Can surgery in family members with medullary thyroid cancer be safely delayed until calcitionin levels rise?
  • Does thyroid cancer staging in younger patients need to be re-evaluated?

We welcome your feedback and suggestions. Let us know what you want to see in this publication. I hope you find these summaries interesting and informative.

— Alan P. Farwell, MD

HYPERTHYROIDISM Updating the diagnostic criteria of thyroid storm

HYPERTHYROIDISM New test may help predict which patients with Graves' disease will remain in remission after stopping antithyroid drugs

HYPOTHYROIDISM Hypothyroidism in patients with pituitary disease may be present even when the standard tests are normal

HYPERTHYROIDISM TSH secreting tumors can be cured by long term octreotide treatment

THYROID CANCER Surgical treatment of RET mutation–positive medullary cancer can be based on measurement of calcitonin levels

THYROID CANCER Cancer staging for younger patients with extensive thyroid cancer needs to be re-evaluated


Support thyroid research and education today with your donation to the ATA!

The ATA exists to serve you by supporting educational information and clinical management guidelines for physicians and patients. Your contribution supports:

  • ATA sponsored Clinical Management Guidelines available free online
  • The latest in Thyroid Health Education for patients and the public
  • Scientific research dedicated to advancing patient care
  • Top-notch endocrinologists from around the world listed on physician referral for patients
  • Publications of the latest clinical research: Clinical Thyroidology and Clinical Thyroidology for Patients

So please, take a moment to Donate Today!

Donate

You are appreciated by the American Thyroid Association for your contribution!

Click here to forward this e-mail to a friend!

American Thyroid Association
6066 Leesburg Pike
Suite 550
Falls Church, Virginia 22041
e-mail: thyroid@thyroid.org
website: www.thyroid.org



This email was sent to you by the American Thyroid Association because you subscribed to our Friends of the ATA e-news mailing list. To ensure delivery to your inbox, please add ata@atafriends.thyroid.org to your address book or safe list.

Click here to modify your profile.

Click here to delete yourself from this email list.

 

If you prefer not to receive these informational emails, you may click here or reply to this message and put UNSUBSCRIBE in the subject line.

Medical Disclaimer
The information contained in or made available through the American Thyroid Association Website is not intended to replace the services of a trained health professional or to be a substitute for medical advice of physicians. The user should consult a physician in all matters relating to his or her health, and particularly in respect to any symptoms that may require diagnosis or medical attention.

We respect your privacy. For more information, view our privacy policy.

PLEASE DO NOT REPLY TO THIS MESSAGE. For questions or comments, please contact thyroid@thyroid.org